Intervention Review

Tamoxifen for relapse of ovarian cancer

  1. Chris Williams1,*,
  2. Iveta Simera2,
  3. Andrew Bryant3

Editorial Group: Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group

Published Online: 17 MAR 2010

Assessed as up-to-date: 1 FEB 2010

DOI: 10.1002/14651858.CD001034.pub2

How to Cite

Williams C, Simera I, Bryant A. Tamoxifen for relapse of ovarian cancer. Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No.: CD001034. DOI: 10.1002/14651858.CD001034.pub2.

Author Information

  1. 1

    Royal United Hospital, Cochrane Gynaecological Cancer Review Group, Bath, UK

  2. 2

    NDORMS, University of Oxford, Centre for Statistics in Medicine, Oxford, UK

  3. 3

    Newcastle University, Institute of Health & Society, Newcastle upon Tyne, UK

*Chris Williams, Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Combe Park, Bath, BA1 3NG, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 MAR 2010


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.